UBS Group’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-159,200
Closed -$3.22M 10355
2025
Q1
$3.22M Sell
159,200
-150,400
-49% -$3.04M ﹤0.01% 4248
2024
Q4
$6.28M Buy
309,600
+185,600
+150% +$4.02M ﹤0.01% 3575
2024
Q3
$2.84M Buy
+124,000
New +$2.67M ﹤0.01% 3660
2018
Q3
Sell
-11,000
Closed -$284K 8029
2018
Q2
$284K Sell
11,000
-2,000
-15% -$47.2K ﹤0.01% 4719
2018
Q1
$302K Buy
+13,000
New +$302K ﹤0.01% 4516
2016
Q2
Sell
-400,770
Closed -$11.9M 7771
2016
Q1
$11.9M Buy
+400,770
New +$12M 0.01% 1213
2015
Q4
Sell
-249,795
Closed -$8.47M 8385
2015
Q3
$8.47M Buy
249,795
+248,587
+20,578% +$8.6M 0.01% 1517
2015
Q2
$40K Sell
1,208
-110
-8% -$4K ﹤0.01% 6196
2015
Q1
$52K Sell
1,318
-1,098
-45% -$44.1K ﹤0.01% 5996
2014
Q4
$97K Buy
+2,416
New +$95.9K ﹤0.01% 5729

Other funds holding DOC

UBS Group's DOC Position: Q2 2026 in Review

UBS Group reduced its Healthpeak Properties (DOC) stake by 64% in Q2 2026, selling an estimated $43.2M and leaving 1,302,948 shares worth $27.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

UBS Group first reported a position in DOC in Q4 2014 and has held it in 47 quarters since. The position peaked at $69.1M in Q4 2024. 761 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • UBS Group held 1,302,948 shares of Healthpeak Properties worth $27.9M as of Q2 2026.
  • UBS Group sold 2,315,135 Healthpeak Properties shares in Q2 2026, an estimated $43.2M.
  • Healthpeak Properties made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2340 holding.
  • UBS Group first reported a position in Healthpeak Properties in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Healthpeak Properties position peaked at $69.1M in Q4 2024.
  • 761 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.